Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pegg

Showing results (1161-1170 of 1,192) with videos related to

Pageof 120
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant gliomaH S Friedman, D M Kokkinakis, J Pluda, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 2014
Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancerSvend O Freytag, Hans Stricker, Mei Lu, et al.
Advances in Therapy|June 25, 2010
Human monoclonal antibodies to the insulin-like growth factor 1 receptor inhibit receptor activation and tumor growth in preclinical studiesHerbert A Runnels, J Alan Arbuckle, Karen S Bailey, et al.
Environmental Pollution (Barking, Essex : 1987)|June 28, 2024
Effect of an antidepressant on aquatic ecosystems in the presence of microplastics: A mesocosm studyNandini Vasantha Raman, Berte M Gebreyohanes Belay, Josie South, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitorsPaul Beswick, Sharon Bingham, Chas Bountra, et al.
Elife|February 16, 2021
A paucigranulocytic asthma host environment promotes the emergence of virulent influenza viral variantsKatina D Hulme, Anjana C Karawita, Cassandra Pegg, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancerSumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
Oncogene|September 12, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancerSumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
British Journal of Cancer|November 20, 2020
Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivityAdan Pinto-Fernandez, Mariolina Salio, Tom Partridge, et al.
Cancer Cell|November 23, 2023
Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignanciesLuciano Nicosia, Gary J Spencer, Nigel Brooks, et al.
Pageof 120

Showing results (1161-1170 of 1,192) with videos related to

Sort By:
Pageof 120
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant gliomaH S Friedman, D M Kokkinakis, J Pluda, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 2014
Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancerSvend O Freytag, Hans Stricker, Mei Lu, et al.
Advances in Therapy|June 25, 2010
Human monoclonal antibodies to the insulin-like growth factor 1 receptor inhibit receptor activation and tumor growth in preclinical studiesHerbert A Runnels, J Alan Arbuckle, Karen S Bailey, et al.
Environmental Pollution (Barking, Essex : 1987)|June 28, 2024
Effect of an antidepressant on aquatic ecosystems in the presence of microplastics: A mesocosm studyNandini Vasantha Raman, Berte M Gebreyohanes Belay, Josie South, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitorsPaul Beswick, Sharon Bingham, Chas Bountra, et al.
Elife|February 16, 2021
A paucigranulocytic asthma host environment promotes the emergence of virulent influenza viral variantsKatina D Hulme, Anjana C Karawita, Cassandra Pegg, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancerSumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
Oncogene|September 12, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancerSumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
British Journal of Cancer|November 20, 2020
Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivityAdan Pinto-Fernandez, Mariolina Salio, Tom Partridge, et al.
Cancer Cell|November 23, 2023
Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignanciesLuciano Nicosia, Gary J Spencer, Nigel Brooks, et al.
Pageof 120